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Abstract
Introduction: The importance of Plasmodium vivax in malaria elimination is increasingly being recognized, yet little is
known about its population size and population genetic structure in the South Pacific, an area that is the focus of intensified
malaria control.
Methods: We have genotyped 13 microsatellite markers in 295 P. vivax isolates from four geographically distinct sites in
Papua New Guinea (PNG) and one site from Solomon Islands, representing different transmission intensities.
Results: Diversity was very high with expected heterozygosity values ranging from 0.62 to 0.98 for the different markers.
Effective population size was high (129872 to 199533 per site). In PNG population structuring was limited with moderate
levels of genetic differentiation. FST values (adjusted for high diversity of markers) were 0.14–0.15. Slightly higher levels were
observed between PNG populations and Solomon Islands (FST = 0.16).
Conclusions: Low levels of population structure despite geographical barriers to transmission are in sharp contrast to
results from regions of low P. vivax endemicity. Prior to intensification of malaria control programs in the study area, parasite
diversity and effective population size remained high.
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Introduction
Plasmodium vivax is the predominant malaria parasite in many of
the countries undergoing concerted efforts to eliminate the disease,
and presents a major challenge towards control and elimination of
malaria [1]. P. vivax is particularly prevalent throughout the South
Pacific, including Solomon Islands and Papua New Guinea (PNG),
and there are reports of severe outcome of disease, especially from
PNG and West Papua [2,3,4]. Solomon Islands are among the 32
countries that are eliminating malaria, and the number of
confirmed malaria cases decreased by roughly 50% from 2000
to 2010 [5]. PNG is controlling malaria and was the only country
in the Western Pacific region with an increase in cases over the last
decade [1,5].
Population structure can inform interventions against malaria.
Marked differences in allele frequencies between parasite popu-
lations indicate little gene flow, suggesting restricted parasite
migration. Likewise, genetic diversity, gene flow and linkage
disequlibrium (LD) between loci are predicted to influence the
emergence and spread of drug resistance and may affect efficiency
of potential future vaccines [6,7,8]. Where transmission is already
reduced to a low level, genotyping could help to track outbreaks
and to identify the origin of imported malaria cases.
Several P. vivax population genetic studies from local (village) to
intercontinental level were undertaken with samples from Latin
America and South-East Asian countries where P. vivax prevalence
is generally lower than in PNG. Genotyping of microsatellite
markers have revealed considerable genetic differentiation be-
tween populations, suggesting limited gene flow [9,10,11,12].
P. vivax transmission intensity is much higher in PNG compared
to that in the Americas and Asia. To investigate P. vivax population
structure from a setting of high endemicity and to describe its local
variations, we have genotyped 14 molecular markers in 295
samples collected in PNG and Solomon Islands prior to the
intensification of control activities. Three of the study sites were
located in the tropical lowlands of PNG, where transmission is
intense. One site located on the southern highland fringe in PNG
and a site in Solomon Islands, separated by sea from PNG, were
included to study the effect of potential geographical barriers to
transmission.
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Methods
Ethics Statement
This study was performed on an existing sample collection from
previous studies. All samples were anonymized prior to use.
Approval for this study was obtained from the Institutional Review
Board of PNG Institute of Medical Research (amendment to IRB
0919/MRAC 09.24 from the PNG Medical Research Advisory
Committee), the Ethics Committee of Canton Basel (no. 237/11)
and the National Health Research & Ethics Committee of
Solomon Islands (approval no. HRC 12/13). Prior to sample
collection, informed written consent was given by all individuals,
or in case of children by their parents or guardians.
Study Sites and Samples
Archived P. vivax positive DNA samples collected in the course
of earlier studies conducted between 2003 and 2007 were used
[13,14,15,16]. At the start of our comprehensive microsatellite
typing project, information on multiplicity of infection (MOI) was
available for samples from PNG based on the two P. vivax
genotyping markers MS16 and msp1F3 [17]. MS16 showed the
highest resolution of all markers, in addition our previous work
showed that underestimation of MOI is unlikely when these two
markers are typed [18]. Results from MS16 and msp1F3 thus
provided the basis for the selection of preferentially single clone
infections or low multiplicity samples for further analysis. Details
of samples used in this study and their origin are listed in Table 1.
295 P. vivax positive blood samples from four sites in PNG and
one site on Solomon Islands were included in the study. Three of
the study sites in PNG were located in the hyper- to holoendemic
tropical lowlands: Ilaita (n = 132 samples) and Kunjingini (n = 38,
both Maprik District, East Sepik Province) and Alexishafen
(n = 45, Madang Province). The fourth PNG study site was in a
meso-endemic site at the Southern highlands fringe at an altitude
of 1100 metres (n = 39, Sigimaru, Karimui area, Simbu Province)
(Figure 1).
Large parts of the coastal lowlands of PNG are characterized by
high prevalence of P. vivax and P. falciparum with perennial
transmission and mild seasonal variation. In study participants
from the Ilaita site, prevalence by microscopy was 44.3% for P.
vivax, 32.6% for P. falciparum and 4.2% of P. malariae. The incidence
rate of malaria was 2.46 episodes per child per year for P. vivax and
2.56 for P. falciparum [15]. Malaria prevalence is lower in the
highland fringe of Simbu province. In a survey in 2001–2002
prevalence was 8% for P. vivax and 27% for P. falciparum in South
Simbu, where our study site is located [19].
Solomon Islands samples (n = 41) derived from asymptomatic
children.6 months and adults from the Tetere area (Guadalcanal
Province), collected in 2004 and 2005 [16]. At that time
transmission of P. falciparum and P. vivax in the area was considered
mesoendemic. P. vivax prevalence by microscopy was 19.1%
compared to a P. falciparum prevalence of 12.9% ([16] and Marie
Ballif, unpublished results).
Preliminary analysis of longitudinal data from the Ilaita cohort
showed no changes in diversity or structuring of samples over time.
Thus, the collection of samples in different years is not expected to
influence the results.
Genetic Markers and PCR
To allow comparability with previous studies from different
continents [10,12] a panel of 13 well-described and frequently
used size polymorphic P. vivax markers were selected for
genotyping: MS1, MS2, MS5, MS6, MS7, MS8, MS9, MS10,
MS12, MS15, MS16, MS20 [20], Pv3.27 [9,21]. In addition the
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polymorphic F3 region of the merozoite surface protein 1 (msp1F3) was
typed [17,21]. msp1F3 codes for a size polymorphic domain of the
surface antigen MSP1 and could be under balancing selection. To
assess the effect of a potentially non-neutral marker, we have
calculated FST values including and excluding msp1F3, and
excluded msp1F3 from all further analyses.
For MS16 and msp1F3, genotyping results were available from
earlier studies [17,21,22], except for samples from Solomon
Islands, which were typed as described [17]. For the 12 additional
microsatellite markers a semi-nested PCR protocol with 12-plex
primary PCR followed by individual reactions for nested PCR was
applied. Forward primers for the 12 primary PCR assays were
designed and used in combination with previously published
nested reverse primers [9,20] (file S1). PCR products were sized by
capillary electrophoresis and analysed as described [17].
Linkage disequilibrium estimation and analysis of population
structure by STRUCTURE software requires genotyping data
from multi-locus haplotypes. Up to 88% of all individuals in our
study sites carried multiple clone infections (Table 1). From these
infections we included only the predominant clone (based on peak
heights) of each sample into our analysis, all minority clones were
ignored. During method optimization we have genotyped field
samples in triplicate [17]. These experiments showed that the
predominant clone is maintained through nested PCR with only
minor variation in peak height ratios. The same was observed
during amplification of artificial mixtures of parasite strains [23].
To account for this minor variation we have excluded all results
from those markers where the minor allele exceeded 70% of the
peak height of the dominant peak.
Data Analysis
Alleles were binned into 2, 3 or 4 bp bins according to their
repeat unit size using TANDEM 1.08 software [24]. The software
Lositan was used to detect loci that are under positive or balancing
selection. To detect non-neutral loci 100’000 simulations were run
in Lositan under a stepwise mutation model [25,26]. Lositan
software gave no indication of non-neutral loci (including msp1F3),
and all markers were included into further analysis.
The expected heterozygosity HE was determined as a measure
for genetic diversity and was calculated for each marker as follows:
HE~
n
n{1
1{
X
p2i
h i
Figure 1. Spatial distribution of P. vivax endemicity in Papua New Guinea and Solomon Islands in 2010 and origin of P. vivax positive
blood samples analyzed in this study. Colors indicate the model-based geostatistic point estimates of the P. vivax annual parasite incidence
(PvAPI) in 2010 in the 1–99 years age range [53]. Unstable transmission (medium grey areas) is defined as PvAPI ,0.1 per 1000 individuals per year.
Squares indicate the origin of genotyped P. vivax samples from PNG and Solomon Islands.
doi:10.1371/journal.pone.0066041.g001
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where n is the number of clones and pi the frequency of allele i.
Linkage disequilibrium (LD) was assessed using the program LIAN
3.5 applying a Monte Carlo test with 100’000 random resamplings
[27]. LIAN cannot handle missing data, thus 6 markers and
subsequently all samples still containing missing data were
removed from the data set. The remaining dataset included 165
samples and the markers MS2, MS7, MS9, MS10, MS12, MS15,
MS16 and MS20 (Table 2). In addition, a reduced dataset (107
samples) including only samples with 1 allele detected for these 8
markers was analysed. To confirm that LD estimates were not
influenced by selection of markers, we have re-run different
combinations of markers and found similar results. The standard-
ized index of association IA
S was calculated as an estimation of LD.
IA
S is zero for linkage equilibrium.
To compare allelic frequencies between populations, Weir &
Cockerham FST values were calculated using Fstat version 2.9.3.2
[28]. In the case of highly diverse markers such as microsatellites,
FST values are downwardly biased [29]. To ensure comparability
to other studies we have calculated in addition corrected FST
values that are adjusted for the high diversity of our markers using
RecodeData 0.1 [30]. As a complementary approach to assess
population structure, we have analysed haplotypes using STRUC-
TURE 2.3.2 [31]. This algorithm attempts to form groups of
haplotypes without prior information on the origin of a sample
and is able to detect genetic differences among subgroups that do
not correlate with geography. The number of populations (K) was
set from 1 to 10 with 3 replications per K, each with 100’000
Markov Chain Monte Carlo steps after a burn-in period of 109000
steps, using the admixture model. In order to determine the most
probable number of populations, DK was calculated, i.e. the
change in the posterior probability of the data for a given K [32].
Principal component analysis (PCA) was done in R using the
prcomp function. Haplotypes containing missing data were
excluded to calculate the covariance matrix, but projected into
the final plot if not more than three data points were missing.
We estimated the long-term effective population size (Ne) using
a similar procedure as for P. falciparum [33]. For three markers
(MS8, MS16, Pv327) the number of different alleles detected was
similar to the number of samples taken. Furthermore, in some
populations the number of samples was even lower than the total
number of different alleles sampled across all populations. A low
number of samples compared to the number of alleles present
across all populations biases the Ne estimates, resulting in values
that are incorrectly high. We thus excluded MS8, MS16 and
Pv3.27 and used only the remaining 10 markers to estimate
effective population size. As estimates of microsatellite mutation
rates (m) are not available for P. vivax, we used estimates for P.
falciparum of 1.5961024 (95% confidence interval: 6.9861025,
3.761024) [34]. For a pure step-wise mutation model (SMM), Ne
is given by
Nem~
1
8
1
1{HE mean
 2
{1
( )
where HE_mean is the mean expected heterozygosity across all
loci. As some loci showed deviation from the SMM model, we also
estimated Ne using the formula for the infinite allele model (IAM):
Nem~
HE mean
4(1{HE mean)
Results
We have genotyped 14 size polymorphic molecular markers in
295 P. vivax positive blood samples from different locations in PNG
and Solomon Islands. All markers were highly polymorphic with
8–81 alleles per locus and HE values of 0.69–0.98. Levels of
diversity were similar at all sites (Table 3). Within all populations,
294 different haplotypes were detected, with one haplotype
detected twice in Sigimaru. No linkage disequilibrium (LD) was
observed in the data, except for samples from Sigimaru in the
PNG highlands (Table 2). No LD was observed in samples from
Sigimaru when only unique haplotypes were analyzed.
We have compared the 5 populations studied by calculating FST
values. Within PNG, uncorrected values were very low (FST = 0 to
0.016, Table 4A), and remained moderate after correcting for high
diversity of markers (FST= 0.14). The population genetic differ-
ence between lowland sites and Sigimaru was not higher than
among lowland sites. Uncorrected FST values ranged from 0.030
to 0.044 between Solomon Islands and PNG, corrected values
ranged from 0.15 to 0.16 (Table 4A). Differences between all
populations were statistically significant when using the corrected
data set (P,0.005).
As an alternative approach to assess population structure we
have searched for clustering of genotypes without prior informa-
tion on the origin of samples using STRUCTURE software. The
most likely number of clusters (K) was 2, with separation between
samples from PNG and Solomon Islands and thus following
geographical structure (Figure 2). No sub-structuring was found
within PNG as STRUCTURE is not adequate for detection of
very low, yet significant FST values [35]. Principal component
analysis did not reveal any grouping of haplotypes according to
their origin, further confirming absence of marked population
structure (Figure 3).
We have calculated effective population size in the sampled
populations. Ne (with SMM) ranged from 12,872 to 22,528
(Table 5). When all populations from PNG were pooled (a
reasonable assumption as populations were genetically similar), Ne
was 25,919. Due to the very high diversity of the populations
studied confidence intervals were large. Estimates based on IAM
were around 3 times lower.
In addition to the 13 presumably neutral microsatellite markers,
we have genotyped the marker msp1F3, which encodes intragenic
repeats of the P. vivax merozoite surface protein MSP1. This
Table 2. Linkage disequilibrium between 8 markers (MS2,
MS7, MS9, MS10, MS12, MS15, MS16, MS20) determined by
LIAN software.
All samples MOI =1
#
samples IA
S P
#
samples IA
S P
Ilaita 74 0.0049 0.131 47 0.0065 0.143
Kunjingini 23 0.021 0.0557 17 0.0164 0.183
Alexishafen 35 20.0001 0.516 30 20.0001 0.515
Sigimaru 22 0.0248 0.0422 12 0.1073 0.00028a
Solomons 11 20.0135 0.758 NA NA NA
All 165 0.0032 0.0739 107 0.0036 0.113
aLinkage in Sigimaru was not significant if only unique haplotypes were
analyzed (11 samples, IA
S= 0.0037, P=0.400.
doi:10.1371/journal.pone.0066041.t002
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marker might be subject to selection. We have calculated FST-
values for msp1F3 alone (Table 4B) and for a combined dataset of
the 13 microsatellites and msp1F3 (Table 4C). FST values were
similar for all data sets. No indication for balancing selection for
msp1F3 was found. Instead differences in msp1F3 allelic frequencies
between PNG and Solomon Islands were observed. The
predominant allele in PNG of 265 bp in size reached a frequency
of 0.24 in the Ilaita cohort [17], whereas in Solomon Islands its
frequency was 0.48. In contrast, the second most frequent allele in
the Ilaita cohort (238 bp in size, frequency = 0.17) was detected in
Solomon Islands a single time, only when also minority clones
were included and thus the number of clones was increased to 99.
Discussion
Four human Plasmodium species, P. falciparum, P. vivax, P. malariae
and P. ovale, coexist in PNG, with probably the highest P. vivax
prevalence anywhere in the world. While P. vivax prevalence was
44% in the Ilaita study site, it was 19% in neighboring Solomon
Islands.
The population genetic structure from these South Pacific sites
is in sharp contrast to the one in Latin America, where P. vivax is
the predominant malaria parasite, but endemicity is usually low
[9,10,11,12]. Within PNG and Solomon Islands the genetic
composition of P. vivax populations differed only moderately with
FST values around 0.15, despite geographical barriers to trans-
mission, i.e. largely malaria free mountain ranges between
Sigimaru and the lowland sites in PNG and a distance of up to
seventeen hundred km between sampling sites in PNG and
Solomon Islands. In contrast FST values were 0.4–0.7 between five
sites in Colombia [9]. Even on a scale of 2 to 50 km distance
between sites in Peru high levels of population differentiation were
found [10]. P. vivax is also the predominant Plasmodium species in
many Asian countries, inter-country FST-values ranged from 0.13–
0.45 between populations from India, Laos and Thailand [9].
Differentiation between P. vivax populations in PNG was low also
in comparison to sympatric P. falciparum populations from lowland
PNG (uncorrected FST-values P. falciparum: 0.05–0.14 [36] vs. P.
vivax 0.030 to 0.044). Microsatellite diversity in Solomon Islands
was similar to PNG, despite its relative geographical isolation. The
moderate P. vivax population structure in the South-West Pacific is
contrasting the pattern observed in the human population that
revealed major differences between cultural and linguistic groups
on small geographical scales [37].
Differences in transmission levels, effective population size,
geographical isolation, recent control and elimination efforts and
the history of malaria radiation may all contribute to the difference
in P. vivax population structure between the South-West Pacific,
South America and South-East Asia. The origin of P. vivax in
South America is unclear. Malaria was likely brought to the
Amazon by European conquerors 1492 onwards and continuing
slave trade [38]; however an earlier independent introduction
from Melanesia to the Pacific coast cannot be ruled out. The
current substructure might be a consequence of independent
introductions, especially since P. vivax in the Americas has never
reached a prevalence as high as in PNG, and it was close to
elimination a few decades ago. In the South Pacific P. vivax arrived
much earlier than in the Americas, possibly together with the first
human settlers 309000 to 509000 years ago and was the
predominant malaria species prior to the start of malaria control
in the second half of the 20th century [39]. The samples used in
this study were collected prior to recently intensified malaria
control interventions and thus reflect a situation of intense
transmission. While in PNG combination therapy with chloro-
quine or amodiaquine plus sulfadoxine–pyrimethamine was
introduced in 2000 [39], large scale distribution of insecticide
treated bed nets has only started after sample collection for this
study. In Solomon Islands, malaria control largely ceased during
the civil unrest between 1998 and 2002 and was only intensified in
2003 [5].
We estimated very high values for the effective population size,
comparable or above the P. falciparum Ne in areas of high
Table 3. Characteristics and expected heterozygosity HE of 14 P. vivax genotyping markers overall and separately for 5
populations from PNG and Solomon Islands.
Marker Chromo-some
size range
(bp)
no. of
alleles expected heterozygosity HE
Overall Ilaita Kunjingini Alexishafen Sigimaru Solomons
MS1 3 221–251 9 0.69 0.67 0.69 0.70 0.75 0.71
MS2 6 168–380 24 0.91 0.91 0.93 0.93 0.89 0.89
MS5 6 143–197 15 0.88 0.86 0.85 0.89 0.84 0.77
MS6 11 210–255 12 0.85 0.85 0.88 0.85 0.74 0.83
MS7 12 138–243 17 0.79 0.75 0.80 0.83 0.78 0.87
MS8 12 181–334 39 0.96 0.97 0.96 0.96 0.95 0.93
MS9 8 152–173 8 0.80 0.77 0.86 0.87 0.77 0.74
MS10 13 156–213 20 0.90 0.90 0.88 0.86 0.90 0.74
MS12 5 168–231 10 0.69 0.65 0.62 0.71 0.70 0.80
MS15 5 231–291 20 0.89 0.87 0.87 0.90 0.89 0.84
MS16 9 194–572 81 0.98 0.98 0.97 0.97 0.97 0.90
MS20 10 158–251 28 0.93 0.91 0.91 0.90 0.92 0.92
Pv3.27 3 184–460 33 0.93 0.93 0.93 0.94 0.93 0.84
msp1F3 7 237–372 30 0.84 0.83 0.74 0.90 0.88 0.72
Mean 24.7 0.861 0.845 0.849 0.872 0.851 0.822
doi:10.1371/journal.pone.0066041.t003
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endemicity [33,40,41], confirming recent suggestions that P. vivax
exhibits a larger effective population size than P. falciparum [42].
Estimates of effective population size based on heterozygosity
reflect long term processes because HE is changing very slowly
over time. Therefore HE is not a reliable indicator for studying
contemporary demographic processes. We also tried to estimate
contemporary Ne using LD estimation [43,44], but all estimates
provided an infinite population size. It is known from theoretical
expectations [43] and empirical studies [45] that high Ne reduces
the precision of estimates and infinite values are likely. Despite the
difficulty to compute contemporary Ne, it is clear that Ne is very
high in all our population.
High Ne reduces the rate of genetic drift and thus the amount of
gene-flow required to counteract population differentiation.
Further aspects of P. vivax biology facilitate break down of
population structure despite a relatively low level of human
migration within PNG and between PNG and Solomon Islands.
Firstly, P. vivax can relapse from dormant liver-stages months or
years after the initial infection. Secondly, clinical immunity to P.
vivax is acquired very rapidly. Under high exposure the incidence
of clinical P. vivax peaks in children below 2 years and by 5 years of
age children in PNG have acquired almost complete clinical
immunity to P. vivax [15,46]. The prevalence of asymptomatic
infections however remains high even in adults [47]. Similarly high
rates of asymptomatic infections are also observed in Solomon
Islands [48]. P. falciparum is less latent and thus shows a higher
degree of population structure. Differences between the two
species are also evident in the highlands of PNG, where high
diversity of P. vivax reflects endemic transmission, while clonal P.
falciparum population structure suggests on outside introduction
[49]. Because of the high diversity of our microsatellite markers, a
more fine-scale P. vivax population structure within PNG could
have escaped detection, but might be revealed using slower
evolving markers such as SNPs.
As a combined result of intense transmission, relapses and
acquired immunity many individuals carry multiple clone P. vivax
infections [17], which might affect P. vivax population structure.
Sexual recombination is only possible in the mosquito after uptake
of gametocytes of different parasite strains. This is more likely in
the case of high multiplicity in the human host. Low levels of
sexual recombination result in clonal population structure with
high LD and possibly a high degree of separation between nearby
Table 4. Genetic differentiation of P. vivax populations in
Papua New Guinea and Solomon Islands.
A) 13 microsatellites
Ilaita Kunjingini AlexishafenSigimaru Solomons
Ilaita 20.002 0.010* 0.013* 0.041*
Kunjingini 0.148* 0.002 0.008 0.049*
Alexishafen 0.142* 0.136* 0.019* 0.033*
Sigimaru 0.152* 0.147* 0.140* 0.050*
Solomons 0.160* 0.156* 0.149* 0.160*
B) Marker msp1F3 alone
Ilaita Kunjingini AlexishafenSigimaru Solomons
Ilaita 20.006 0.035* 0.011* 0.046*
Kunjingini 0.209* 0.055 0.013 0.023
Alexishafen 0.138* 0.173* 0.007 0.064*
Sigimaru 0.151* 0.189* 0.110* 0.022
Solomons 0.217* 0.268* 0.181* 0.198*
C) Combination of 13 microsatellites and msp1F3
Ilaita Kunjingini AlexishafenSigimaru Solomons
Ilaita 20.002 0.012* 0.013* 0.042*
Kunjingini 0.153* 0.006** 0.008** 0.048*
Alexishafen 0.142* 0.139* 0.018* 0.035*
Sigimaru 0.152* 0.150* 0.138 0.048*
Solomons 0.164* 0.164* 0.151 0.163*
FST values for inter-site comparisons are given. The upper-right section shows
uncorrected values. In the lower-left section FST values are corrected to adjust
for high diversity of our microsatellite markers (see methods for details).
(A) results obtained from 13 microsatellite markers.
(B) results obtained from marker msp1F3 only.
(C) results obtained from 13 microsatellite markers and msp1F3.
*significant at the Bonferroni-corrected 5% level (P,0.005).
**significant at the 5% level (P,0.05).
doi:10.1371/journal.pone.0066041.t004
Figure 2. Output of clustering analysis by STRUCTURE Software for 2 clusters (K=2). Each column represents one haplotype, the green
and red colours show whether an isolate was assigned to cluster 1 or cluster 2. If both colours are present, the haplotype consists of a mixture of
markers assigned to cluster 1 and to cluster 2. The samples from Solomon Islands were assigned mostly to one cluster (red), while samples from PNG
contain alleles of both clusters.
doi:10.1371/journal.pone.0066041.g002
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populations. A high frequency of recombination breaks LD and is
expected when transmission is intense and parasite genotypes
circulate between different populations. In our study populations
in PNG and Solomon Islands, the proportion of people carrying
multiple clone infections ranged from 63% to 88% (Table 1). In
areas of low P. vivax transmission this proportion ranged from 13%
in Sri Lanka [50] to 10–34% in South America [9,10] or 30–35%
in Thailand and Laos [9]. Absence of LD in our data (with the
exception of Sigimaru, where inclusion of a haplotype occurring
twice lead to significant LD) further implies a high frequency of
sexual recombination. High LD was reported previously from low
Figure 3. Principal component analysis of P. vivax haplotypes genotyped with 13 microsatellite markers in 4 populations from PNG
and one site in Solomon Islands. Haplotypes were clustered to show maximal differentiation. The first principal component (PC1) has the largest
possible variance (i.e. it accounts for as much of the variability in the data as possible), the second principal component (PC2) has the second largest
possible variance. Isolates do not cluster according to their geographic origin, indicating absence of pronounced population structure.
doi:10.1371/journal.pone.0066041.g003
Table 5. Effective population size Ne per study site and for PNG populations pooled. Estimates are based on 10 microsatellite
markers (MS1, MS2, MS5, MS6, MS7, MS9, MS10, MS12, MS15, MS20).
PNG Ilaita Kunjingini Alexishafen Sigimaru Solomons
SMM [95% CI] 25919
[11138–59043]
19533
[8394–44496]
15970 [6862–36379] 22528 [9681–51317] 14716 [6324–33523] 12872 [5531–29322]
IAM [95% CI] 7591 [3262–17293] 6421 [2759–14627] 5686 [2443–12953] 6990 [3003–15923] 5409 [2324–12323] 4981 [2140–11347]
Estimates are calculated using a stepwise mutation model (SMM) and an infinite allele model (IAM), and are given for each population from PNG and Solomon Islands
separately as well as for samples from PNG pooled.
doi:10.1371/journal.pone.0066041.t005
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transmission areas, such as the Amazon [9,10,51], Sri Lanka or
Ethiopia [11,12].
The high proportion of P. vivax multi-clone infection contrasts
with the situation in P. falciparum populations from lowland PNG
with moderate population structuring, where 39–44% of infected
individuals carried multiple clones [36]. In the Ilaita cohort, from
which part of our samples derived, 33% of P. falciparum positive
children carried multiple clone infections (Sonja Schoepflin,
unpublished), in contrast to 73% multiple-clone infections for P.
vivax [17].
While our 13 microsatellite markers are presumable neutral,
msp1F3 encodes a highly polymorphic region of the MSP1 antigen.
Our amplified fragment is located approximately 1 kb upstream of
the highly antigenic C-terminal MSP119 fragment which is a
widely studied vaccine candidate (reviewed in [52]). Consequently,
balancing selection could be expected to act on msp1F3, but we did
not detect evidence for this in our data.
Conclusions
We present the first comparison of P. vivax populations in the
South Pacific based on genotyping results from neutral markers.
At all study sites we observed very high diversity of parasite
genotypes and very high population sizes. Only moderate
population sub-structuring was observed even after correcting
for the high diversity of markers, despite geographic and social
barriers among our study sites. Solomon Islands and Vanuatu
represent the south-western boarder of global malaria transmis-
sion, and restricted parasite diversity and increasing sub-division
between populations is expected towards the spatial limits of
malaria endemicity. At the time of sample collection this effect was
not evident in Solomon Islands.
Due to the high population size, we cannot precisely estimate
the amount of gene flow among our study sites. Further research is
warranted to investigate how the continued intensification of
malaria control affects the levels of P. vivax population differen-
tiation across an extended geographic region, e.g. including
Indonesia, Malaysia and the Philippines. Once prevalence is
substantially reduced, future attempts to control malaria trans-
mission in regions of previously high P, vivax endemicity need to
carefully consider migration of infected hosts, even in island
settings. Our results illustrate that control programs coordinated
between countries and also targeting asymptomatic carriers seem
to be needed in order to move towards elimination of P. vivax in
the South Pacific.
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